Improving engagement in HIV care for underserved populations
Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care
This study is looking for ways to help people in underserved urban areas stay connected to their HIV care by understanding what makes it hard for them and finding new solutions, like using telehealth and long-lasting treatments, to improve their health and support new researchers in the process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10873904 on NIH RePORTER |
What this research studies
This research focuses on enhancing the engagement of underserved urban populations in HIV care. It aims to identify individuals at risk of poor engagement and understand the barriers and facilitators that affect their participation in care. The project will develop and evaluate interventions, including innovative approaches like telehealth and long-acting injectable therapies, to improve retention in care and achieve better health outcomes. The research also emphasizes mentorship for early career investigators to foster a new generation of researchers in this field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from underserved urban populations who are living with HIV and may struggle with engagement in care.
Not a fit: Patients who are not living with HIV or those who are already well-engaged in their HIV care may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access and adherence to HIV care, ultimately enhancing health outcomes for patients.
How similar studies have performed: Previous research has shown success in using innovative care delivery methods, such as telehealth, to improve patient engagement in HIV care.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Christopoulos, Katerina a — University of California, San Francisco
- Study coordinator: Christopoulos, Katerina a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.